Why Chindex (CHDX) Hit a Five-Year High Today
Chindex (CHDX) spiked to a five-year high of $19.71 on Tuesday after the announcement that TPG and Shanghai Fosun Pharmaceutical would acquire the drug manufacturer. The deal is worth $369 million, and the consortium will pay $19.50 per share in cash for Chindex. Founder and Chief Executive Officer Roberta Lipson will stay on as CEO after the deal. The deal should give TPG and Fosun a foothold in China's private healthcare sector, which has been growing quickly as the Chinese government invests in it to alleviate pressure on public hospitals and to drive down prices through more competition in the market.
Feb. 18 Premarket Briefing: 10 Things You Should Know
U.S. stock futures are flat; Actavis reportedly in talks to buy Forest Labs for $25 billion; Coca-Cola and Duke Energy to report earnings on Tuesday; profit at BHP Billiton rises.
Chindex International Inc. Stock Downgraded (CHDX)
Chindex International (Nasdaq:CHDX) has been downgraded by TheStreet Ratings from from a buy to hold.
Gap Stock Slumps On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel
"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.
Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending
"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.